|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002658,
umls-concept:C0013227,
umls-concept:C0021125,
umls-concept:C0025810,
umls-concept:C0033929,
umls-concept:C0034693,
umls-concept:C0086960,
umls-concept:C0231441,
umls-concept:C0237753,
umls-concept:C0443218,
umls-concept:C0870186,
umls-concept:C1280500,
umls-concept:C1314677,
umls-concept:C1707491,
umls-concept:C2003874,
umls-concept:C2827483
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-6-10
|
|
pubmed:abstractText |
Impulsive behaviour is a component of psychiatric disorders such as bipolar disorder, attention deficit hyperactivity disorder (ADHD), or personality disorders. Most experimental studies on impulsive behaviour punish impulsive choices by loss or delay of reward. In the present study, impulsive behaviour was punished by an explicitly aversive stimulus, using a novel fixed consecutive number (FCN) schedule of electric shock avoidance.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0033-3158
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
180
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
294-305
|
|
pubmed:meshHeading |
pubmed-meshheading:15717210-Animals,
pubmed-meshheading:15717210-Avoidance Learning,
pubmed-meshheading:15717210-Chlordiazepoxide,
pubmed-meshheading:15717210-Conditioning, Operant,
pubmed-meshheading:15717210-Dextroamphetamine,
pubmed-meshheading:15717210-Dose-Response Relationship, Drug,
pubmed-meshheading:15717210-Ethanol,
pubmed-meshheading:15717210-Haloperidol,
pubmed-meshheading:15717210-Imipramine,
pubmed-meshheading:15717210-Methylphenidate,
pubmed-meshheading:15717210-Rats,
pubmed-meshheading:15717210-Rats, Long-Evans,
pubmed-meshheading:15717210-Reinforcement Schedule
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
The psychopharmacology of impulsive behaviour in rats VIII: effects of amphetamine, methylphenidate, and other drugs on responding maintained by a fixed consecutive number avoidance schedule.
|
|
pubmed:affiliation |
CNS Discovery, AstraZeneca R & D Wilmington, Wilmington, DE 19850, USA. john.evenden@astrazeneca.com
|
|
pubmed:publicationType |
Journal Article
|
